BLTP2 and cancer: As in our design shown in Figure 2, where MDA-MB-231 cells were maintained in suspension, the ability to re-anchor and invade/migrate across ECM could then be assessed by a BME assay, and the effect of silencing KIAA0100 expression on the cancer cells could then be evaluated.